Tandem Autologous Transplantation Can Overcome the Poor Prognosis of Double-Hit Multiple Myeloma Patients With 1q21 Gain/Amp and t(4;14)

被引：0
|
作者：
Huang, Beihui [1 ]
Li, Juan [1 ]
Wang, Xiuju [2 ]
Huang, Hongming [3 ]
Xu, Xiaojun [4 ]
Wu, Bingyi [5 ]
机构：
[1] Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou, Peoples R China
[2] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Guangzhou, Peoples R China
[3] Nantong Univ, Affiliated Hosp, Nantong, Peoples R China
[4] Sun Yat Sen Univ, Affiliated Hosp 7, Guangzhou, Guangdong, Peoples R China
[5] Sun Yat Sen Univ, Canc Ctr, Guangzhou, Peoples R China
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-339
引用
收藏
页码：S229 / S229
页数：1
相关论文
共 50 条
  • [11] Proteasome inhibitors and IMiDs can overcome some high-risk cytogenetics in multiple myeloma but not gain 1q21
    Nahi, Hareth
    Vatsveen, Thea Kristin
    Lund, Johan
    Heeg, Bart M. S.
    Preiss, Birgitte
    Alici, Evren
    Moller, Michael Boe
    Wader, Karin Fahl
    Moller, Hanne E. H.
    Groseth, Lill Anny
    Ostergaard, Brian
    Dai, Hong Yan
    Holmberg, Erik
    Gahrton, Gosta
    Waage, Anders
    Abildgaard, Niels
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2016, 96 (01) : 46 - 54
  • [12] The prognostic role of 1q21 gain/amp in newly diagnosed multiple myeloma: the faster, the worse
    Wang, Yawen
    Xu, Jiadai
    Liu, Peng
    Li, Panpan
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S160 - S160
  • [13] Gain of 1q21 is an adverse prognostic factor for multiple myeloma patients treated by autologous stem cell transplantation: A multicenter study in China
    Gao, Wen
    Jian, Yuan
    Du, Juan
    Li, Xiaozhe
    Zhou, Huixing
    Zhang, Zhiyao
    Yang, Guangzhong
    Wang, Guorong
    Tian, Ying
    Li, Yanchen
    Wu, Yin
    Fu, Weijun
    Li, Juan
    Chen, Wenming
    CANCER MEDICINE, 2020, 9 (21): : 7819 - 7829
  • [14] Effect of amplification or gain of 1Q21 in patients with multiple myeloma treated with daratumumab
    Zamanillo, Irene
    Medina de Alba, Lucia
    Alonso, Rafael
    Maria Sanchez, Jose
    Cuellar, Clara
    Fernandez-Guijarro, Manuela
    Martinez-Lopez, Joaquin
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S235 - S236
  • [15] Filanesib plus bortezomib and dexamethasone in relapsed/refractory t(11;14) and 1q21 gain multiple myeloma
    Pan, Darren
    Kaufman, Jonathan L.
    Htut, Myo
    Agrawal, Manish
    Mazumder, Amitabha
    Cornell, Robert F.
    Zonder, Jeffrey A.
    Fay, Joseph W.
    Modiano, Manuel R.
    Moshier, Erin L.
    Rush, Selena A.
    Tunquist, Brian J.
    Chari, Ajai
    CANCER MEDICINE, 2022, 11 (02): : 358 - 370
  • [16] Efficacy of daratumumab in newly diagnosed multiple myeloma patients with 1q21 gain
    Iriuchishima, Hirono
    Saito, Akio
    Mihara, Masahiro
    Terasaki, Yukie
    Matsumoto, Akira
    Isoda, Atsushi
    Furukawa, Yusuke
    Matsumoto, Morio
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2024, 120 (01) : 71 - 79
  • [17] Additional genetic abnormalities significantly worsen poor prognosis associated with 1q21 amplification in multiple myeloma patients
    Grzasko, Norbert
    Hus, Marek
    Pluta, Andrzej
    Jurczyszyn, Artur
    Walter-Croneck, Adam
    Morawska, Marta
    Chocholska, Sylwia
    Hajek, Roman
    Dmoszynska, Anna
    HEMATOLOGICAL ONCOLOGY, 2013, 31 (01) : 41 - 48
  • [18] Amp 1q21 is more predictable with dismal survival than gain 1q21 of newly diagnosed multiple myeloma in real-world analysis
    Wang, Yu-Tong
    Bao, Li
    Chu, Bin
    Chen, Xiao-Huan
    Lu, Min-Qiu
    Shi, Lei
    Gao, Shan
    Fang, Li-Juan
    Xiang, Qiu-Qing
    Ding, Yue-Hua
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2022, 36 (07)
  • [19] Efficacy Analysis of Bortezomib Combined with Lenalidomide in Newly Diagnosed Multiple Myeloma with 1q21 Gain/Amp
    Zhou, Qiaolin
    Wen, Jingjing
    Xu, Fang
    Yue, Jing
    Zhang, Ya
    Su, Jing
    Liu, Yiping
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2024, 23
  • [20] Autologous stem cell transplant can overcome poor prognosis in patients with multiple myeloma with extramedullary plasmacytoma
    Li, Jian
    Shen, Kai-Ni
    Huang, Wen-Rong
    Li, Li-Hong
    Chen, Huan
    Chen, Wen-Ming
    Liu, Kai-Yan
    Yu, Li
    Zhou, Dao-Bin
    LEUKEMIA & LYMPHOMA, 2014, 55 (07) : 1687 - 1690
12345